Aquestive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 9.81 M | $54.84 M | 0.00% | 9.88% |
| BLACKROCK, INC. | 11/12/2025 | 6.53 M | $36.48 M | 0.76% | 6.57% |
| RTW INVESTMENTS, LP | 11/14/2025 | 6.25 M | $34.94 M | 100.00% | 6.29% |
| VANGUARD GROUP INC | 11/07/2025 | 5.66 M | $31.65 M | 30.81% | 5.70% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 3.76 M | $21.02 M | 71.66% | 3.79% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 2.63 M | $14.67 M | 100.00% | 2.64% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 2.50 M | $13.98 M | 100.00% | 2.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.09 M | $11.67 M | 5.61% | 2.10% |
| STATE STREET CORP | 11/14/2025 | 1.60 M | $8.96 M | 6.30% | 1.61% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 1.50 M | $8.37 M | 58.11% | 1.51% |
| MORGAN STANLEY | 11/14/2025 | 1.41 M | $7.88 M | -0.28% | 1.42% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.29 M | $7.21 M | -56.73% | 1.30% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 1.25 M | $6.99 M | 35.87% | 1.26% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.22 M | $6.83 M | -4.75% | 1.23% |
| JANNEY MONTGOMERY SCOTT LLC | 10/27/2025 | 1.10 M | $6.15 M | 4.44% | 1.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.09 M | $6.09 M | 133.23% | 1.10% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 1.06 M | $5.92 M | 100.00% | 1.07% |
| FEDERATED HERMES, INC. | 11/03/2025 | 783.78 K | $4.38 M | 100.00% | 0.79% |
| CITADEL ADVISORS LLC | 11/14/2025 | 768.45 K | $4.30 M | 405.04% | 0.77% |
| WASATCH ADVISORS LP | 11/14/2025 | 724.28 K | $4.05 M | 100.00% | 0.73% |
| NORTHERN TRUST CORP | 11/14/2025 | 682.87 K | $3.82 M | 6.05% | 0.69% |
| ABRDN PLC | 11/07/2025 | 625.00 K | $3.49 M | 100.00% | 0.63% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 600.00 K | $3.35 M | 100.00% | 0.60% |
| HRT FINANCIAL LP | 11/14/2025 | 560.21 K | $3.13 M | 100.00% | 0.56% |
| NUVEEN, LLC | 11/12/2025 | 544.62 K | $3.04 M | 170.39% | 0.55% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 512.59 K | $2.87 M | 260.98% | 0.52% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 505.27 K | $2.82 M | 112.39% | 0.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 500.00 K | $2.80 M | 100.00% | 0.50% |
| UBS GROUP AG | 11/13/2025 | 499.04 K | $2.79 M | 38.14% | 0.50% |
| JPMORGAN CHASE & CO | 11/26/2025 | 473.58 K | $2.65 M | 8.63% | 0.48% |
| BRACEBRIDGE CAPITAL, LLC | 11/14/2025 | 459.22 K | $2.57 M | 0.00% | 0.46% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 395.15 K | $2.21 M | -24.69% | 0.40% |
| MARSHALL WACE, LLP | 11/13/2025 | 371.07 K | $2.07 M | 411.26% | 0.37% |
| EVERSTAR ASSET MANAGEMENT, LLC | 11/10/2025 | 368.29 K | $2.06 M | -44.08% | 0.37% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 366.43 K | $2.05 M | -2.08% | 0.37% |
| ROYAL BANK OF CANADA | 11/14/2025 | 363.40 K | $2.03 M | 6.44% | 0.37% |
| HARVEY CAPITAL MANAGEMENT INC | 10/31/2025 | 343.76 K | $1.92 M | 3.00% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 285.78 K | $1.60 M | 16.50% | 0.29% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 254.17 K | $1.42 M | 4.00% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 252.50 K | $1.41 M | 180.87% | 0.25% |
| LATASH INVESTMENTS, LLC | 11/12/2025 | 243.13 K | $1.36 M | 0.00% | 0.24% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 241.36 K | $1.35 M | 29.28% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 207.24 K | $1.16 M | 12.07% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2025 | 204.30 K | $1.14 M | 79.68% | 0.21% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 163.39 K | $913.32 K | 27.94% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 156.50 K | $874.84 K | 220.70% | 0.16% |
| EAM INVESTORS, LLC | 11/14/2025 | 152.33 K | $851.54 K | 100.00% | 0.15% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2025 | 146.02 K | $816.26 K | 100.00% | 0.15% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 145.91 K | $818.40 K | -16.88% | 0.15% |
| CREATIVE PLANNING | 11/14/2025 | 144.66 K | $808.66 K | 46.49% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aquestive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 183 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock, Inc.: 6.53 M
RTW INVESTMENTS, LP: 6.25 M
VANGUARD GROUP INC: 5.66 M
PERCEPTIVE ADVISORS LLC: 3.76 M
EcoR1 Capital, LLC: 2.63 M
66.52% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 72.96 M shares in the last 24 months. This purchase volume represents approximately $423.18 M in transactions.